항생제
Oseltamivir

Oseltamivir

None
Excellent

Spectrum Of Activity

General Information

Treatment and prophylaxis of influenza

Monitor behavior changes.

Common

  • Nausea
  • Vomiting
  • Headache

Serious

  • Cardiac dysrhythmia
  • GI hemorrhage
  • Hemorrhagic colitis
  • Hepatitis
  • Seizure
  • Delirium
  • Abnormal behavior
  • Stevens-Johnson syndrome (rare)
  • Erhtema multiforme (rare)
  • Toxic epidermal necrolysis (rare)
  • Anaphylaxis (rare)
  • Warfarin: increased risk of bleeding
  • Influenza virus vaccine, live

Antimicrobial class: Antiviral agent, Neuraminidase inhibitor

Pregnancy category: C

Average serum half life: 2 hours

Lung penetration: Therapeutic

Higher doses (150 mg PO BID) have not been shown to be superior but may be considered in critically ill or obese patients.

Precautions: Not recommended in renal imapirment (ESRD not undergoing dialysis). Discontinue use if allergic-like reaction occurs. One dose delivers 2 g of sorbitol and may cause dyspepsia or diarrhea in patients with hereditary fructose intolerance. Abnormal behavior and delirium leading to potentially fatal injuries may occur, primarily in pediatric patients.